ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 896 filers reported holding ASTRAZENECA PLC in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,143,334 | +13.0% | 75,950 | +19.4% | 0.05% | +10.9% |
| Q2 2023 | $4,553,283 | -7.1% | 63,620 | -9.9% | 0.05% | -13.2% |
| Q1 2023 | $4,901,888 | -37.6% | 70,622 | -39.1% | 0.05% | -24.3% |
| Q4 2022 | $7,861,207 | -99.9% | 115,947 | -44.7% | 0.07% | +12.9% |
| Q3 2022 | $5,754,749,000 | +80873.0% | 209,666 | +94.9% | 0.06% | -15.1% |
| Q2 2022 | $7,107,000 | +18.4% | 107,569 | +18.9% | 0.07% | +15.9% |
| Q1 2022 | $6,004,000 | +25.8% | 90,499 | +10.5% | 0.06% | +31.2% |
| Q4 2021 | $4,772,000 | -9.0% | 81,917 | -6.1% | 0.05% | -7.7% |
| Q3 2021 | $5,242,000 | +37.1% | 87,281 | +36.8% | 0.05% | +20.9% |
| Q2 2021 | $3,823,000 | +17.3% | 63,816 | -2.6% | 0.04% | +4.9% |
| Q1 2021 | $3,259,000 | +8.9% | 65,540 | +9.8% | 0.04% | +17.1% |
| Q4 2020 | $2,994,000 | -99.9% | 59,670 | +43.9% | 0.04% | -16.7% |
| Q3 2020 | $2,272,000,000 | – | 41,453 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |